Comparison of iron-sucrose with ferric carboxymaltose for treatment of postpartum iron deficiency anaemia

Background: Anaemia is a major public health problem worldwide. Haemoglobin (Hb) cut-off in anaemia should be taken as 11 gm/dl the first and third trimester 10.5 second trimester, post-partum Hb of 10.0 gm/dl. The aim study to compare efficacy iron-sucrose versus ferric carboxymaltose (FCM) treatment postpartum anaemia.Methods: A prospective randomized interventional 132 females was conducted at tertiary care hospital, over 6-month period. Post-partum delivered via normal vaginal delivery or caesarean section with levels above 7 below 9.9 were into 2 groups. Iron deficit calculated, mg, according Ganzoni’s formula. One group received intravenous FCM – 500 mg 250 ml saline (NS) 30 minutes other iron sucrose - each ampoule containing 200 100 NS up maximum dose 1000 mg. Follow done after 15 days, 4 weeks 6 weeks. data tabulated compared using statistical analysis.Results: At follow up, mean rise hemoglobin (1.4 g/dl) significantly greater than that B (0.89 g/dl).Conclusions: concludes thought drugs similar, injection shows prompt Hb, allows higher dispensed single seating more significant improving quality life period time even though it has marginally cost.